Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,076 public trials 1,849 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Completed

Local Recurrence Prediction of by Texture Analysis Derived From Positron Emission Tomography (PET / CT) Imaging of Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Radiotherapy (SBRT) (Retros MUMOFRAT)

NCT06555861

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ICO Nantes, Saint Herblain, France
  • CHRU de Brest Brest, France
  • Centre Eugènes Marquis Rennes, France
  • CHU de Tours Tours, France
View Trial Details
Completed

Real-world Data on Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy in Asia Area (PACIFIC AA)

NCT04529564

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • National Taiwan University Hospital-Hsinchu Branch Hsinchu, Taiwan
  • Chang Gung Medical Foundation-Kaohsiung Branch Kaohsiung City, Taiwan
  • Chang Gung Medical Foundation-Keelung Branch Keelung, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View Trial Details
Completed

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

NCT01970865

Conditions
ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Highlands Oncology Group/Research Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • UC Irvine Medical Center Orange, California, United States
View all 77 locations
View Trial Details
Completed

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

NCT02595866

Conditions
AIDS-Related Non-Hodgkin Lymphoma, Adenocarcinoma, Blood-Borne Infections, +76 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Zuckerberg San Francisco General Hospital San Francisco, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
View Trial Details
Completed

Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)

NCT02679170

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hospital Clínico Univ. de Santiago de Compostela Santiago de Compostela, A Coruña, Spain
  • Hospital Virgen de los Lirios Alcoy, Alicante, Spain
  • Complejo Hospitalario de Jerez Jerez de la Frontera, Cadiz, Spain
  • Hospital Marqués de Valdecilla Santander, Cantabria, Spain
View all 32 locations
View Trial Details

Related conditions